CITRO, VALENTINA
 Distribuzione geografica
Continente #
EU - Europa 1.341
NA - Nord America 1.051
AS - Asia 595
SA - Sud America 81
AF - Africa 12
OC - Oceania 12
Totale 3.092
Nazione #
US - Stati Uniti d'America 1.029
IT - Italia 453
DE - Germania 333
GB - Regno Unito 199
CN - Cina 193
SG - Singapore 184
BR - Brasile 74
IE - Irlanda 68
RU - Federazione Russa 61
IN - India 60
SE - Svezia 60
FR - Francia 45
ID - Indonesia 43
NL - Olanda 25
FI - Finlandia 24
TR - Turchia 21
CA - Canada 20
KR - Corea 16
AT - Austria 15
AU - Australia 12
BE - Belgio 12
JP - Giappone 12
HK - Hong Kong 11
UA - Ucraina 11
VN - Vietnam 11
CH - Svizzera 7
TW - Taiwan 7
CZ - Repubblica Ceca 6
PH - Filippine 6
IR - Iran 5
TH - Thailandia 5
ES - Italia 4
HU - Ungheria 4
IL - Israele 4
PK - Pakistan 4
ZA - Sudafrica 4
DK - Danimarca 3
EG - Egitto 3
HR - Croazia 3
AE - Emirati Arabi Uniti 2
CL - Cile 2
IQ - Iraq 2
KG - Kirghizistan 2
NO - Norvegia 2
NP - Nepal 2
RO - Romania 2
SC - Seychelles 2
UZ - Uzbekistan 2
AO - Angola 1
AR - Argentina 1
BD - Bangladesh 1
CO - Colombia 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
FK - Isole Falkland (Malvinas) 1
GR - Grecia 1
MA - Marocco 1
MD - Moldavia 1
MX - Messico 1
MY - Malesia 1
NG - Nigeria 1
PL - Polonia 1
PT - Portogallo 1
PY - Paraguay 1
QA - Qatar 1
Totale 3.092
Città #
Frankfurt am Main 201
Milan 193
Southend 161
Fairfield 132
Singapore 121
Chandler 105
Ashburn 69
Dublin 68
Hanover 64
Woodbridge 60
Wilmington 51
Cambridge 50
Houston 48
Princeton 48
Seattle 43
Jakarta 42
Council Bluffs 34
Santa Clara 33
Beijing 28
Des Moines 22
New York 21
Ann Arbor 20
Helsinki 20
Naples 17
Bengaluru 14
Eitensheim 13
Boardman 12
London 12
Rome 12
Berlin 11
Brescia 11
San Diego 11
Vienna 11
Redwood City 10
Istanbul 9
Brussels 8
Chicago 8
Nuremberg 8
Amsterdam 7
Fuzhou 7
Shanghai 7
St Louis 7
São Paulo 7
Bodio Lomnago 6
Hyderabad 6
Montreal 6
Piscataway 6
Sydney 6
Toronto 6
Wuhan 6
Bühl 5
Florence 5
Guangzhou 5
Kolkata 5
Manila 5
Meduna di Livenza 5
Nanjing 5
Roxbury 5
Seoul 5
Budapest 4
Hangzhou 4
Jinan 4
Lahore 4
Munich 4
North Bergen 4
Phoenix 4
Reston 4
Segrate 4
Xian 4
Albuquerque 3
Azzano San Paolo 3
Bangkok 3
Boscoreale 3
Brugherio 3
Cartoceto 3
Caserta 3
Dallas 3
Delhi 3
Falkenstein 3
Genoa 3
Guwahati 3
Ilford 3
Johannesburg 3
Kent 3
Lissone 3
Monza 3
Nagoya 3
Nashville 3
New Delhi 3
Ottawa 3
Quanzhou 3
Rende 3
Robbio 3
Romola 3
Senago 3
Villaz-Saint-Pierre 3
Visciano 3
Yubileyny 3
Zagreb 3
Ústí nad Labem 3
Totale 2.056
Nome #
Extracellular vesicles mediate the communication between multiple myeloma and bone marrow microenvironment in a NOTCH dependent way 277
HEBE project: Healthy aging versus inflamm-aging: The role of physical exercise in modulating the biomarkers of age-associated and environmentally determined chronic diseases, study protocol 219
Jagged ligands enhance the pro-angiogenic activity of multiple myeloma cells 182
Different mechanisms cause imprinting defects at the IGF2/H19 locus in Beckwith-Wiedemann syndrome and Wilms' tumour 171
Nanoplastics & health: taking a picture of bone cells 147
Data on the inhibition of cell proliferation and invasion by the D2A-Ala peptide derived from the urokinase receptor 139
Restoring Tissue Homeostasis at Metastatic Sites: A Focus on Extracellular Vesicles in Bone Metastasis 135
Sex Steroid Regulation of Oxidative Stress in Bone Cells: An In Vitro Study 124
Nanoplastic impact on bone microenvironment: A snapshot from murine bone cells 117
Proteostasis regulators modulate proteasomal activity and gene expression to attenuate multiple phenotypes in Fabry disease 109
Challenging popular tools for the annotation of genetic variations with a real case, pathogenic mutations of lysosomal alpha-galactosidase 104
The Potential of JAG Ligands as Therapeutic Targets and Predictive Biomarkers in Multiple Myeloma 95
In silico docking of urokinase plasminogen activator and integrins 94
The molecular function and clinical phenotype of partial deletions of the IGF2/H19 imprinting control region depends on the spatial arrangement of the remaining CTCF-binding sites 83
Therapy of Fabry disease with pharmacological chaperones: from in silico predictions to in vitro tests 82
Heterodimerization of two pathological mutants enhances the activity of human phosphomannomutase2 81
Identification of an Allosteric Binding Site on Human Lysosomal Alpha-Galactosidase Opens the Way to New Pharmacological Chaperones for Fabry Disease 78
Inherited and sporadic epimutations at the IGF2-H19 locus in Beckwith-Wiedemann syndrome and Wilms' tumor 77
A mutant of phosphomannomutase1 retains full enzymatic activity, but is not activated by IMP : possible implications for the disease PMM2-CDG 77
Investigating the Impact of Epstein-Barr Virus on Sphingolipid Composition in Extracellular Vesicles of Multiple Sclerosis Patients 76
Drug repositioning can accelerate discovery of pharmacological chaperones 73
A thermodynamic assay to test pharmacological chaperones for Fabry disease 71
The analysis of variants in the general population reveals that PMM2 is extremely tolerant to missense mutations and that diagnosis of PMM2-CDG can benefit from the identification of modifiers 67
Extracellular Vesicles as an Innovative Tool for siRNA Delivery to Block the Pathological Communication between Tumor and Microenvironment. 62
The role of NOTCH2 in the Extracellular vesicles mediated communication in Multiple Myeloma: a focus on angiogenesis and osteoclastogenesis 61
The large phenotypic spectrum of fabry disease requires graduated diagnosis and personalized therapy: A Meta-Analysis can help to differentiate missense mutations 57
Jagged ligands as new targets in multiple myeloma associated angiogenesis 48
E-Learning for Rare Diseases: An Example Using Fabry Disease 48
D2A-Ala peptide derived from the urokinase receptor exerts anti-tumoural effects in vitro and in vivo 48
In vitro enzyme measurement to test pharmacological Chaperone responsiveness in Fabry and Pompe Disease 46
RNA medicine: a novel approach to block the pathological communication between tumor and microenvironment 44
D2A sequence of the urokinase receptor induces cell growth through αvβ3 integrin and EGFR 42
The role of Notch pathway in the pro-tumorigenic activity of extracellular vesicles in multiple myeloma 40
The role of NOTCH2 in the extracellular vesicles-mediated angiogenesis and osteoclastogenesis in multiple myeloma 35
A splicing mutation of the HMGA2 gene is associated with Silver-Russell syndrome phenotype 35
null 3
Totale 3.247
Categoria #
all - tutte 13.789
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.789


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020130 0 0 0 0 0 0 0 0 24 30 47 29
2020/2021552 62 50 69 47 49 63 31 35 47 31 30 38
2021/2022406 27 22 26 26 18 14 26 13 44 50 69 71
2022/2023458 39 28 50 42 51 75 13 29 61 24 30 16
2023/2024609 14 24 31 41 66 20 39 32 32 54 133 123
2024/20251.058 94 169 92 125 106 93 143 142 94 0 0 0
Totale 3.247